Search Result |
Top |
| Entry | Name | Name(TN) | Disease |
|---|---|---|---|
| D00131 | Disulfiram (JP18/USP/INN) | Antabuse (TN) | Management of selected chronic alcohol patients [DS:H01611] |
| D00252 | Carbamazepine (JP18/USP/INN) |
Equetro (TN) Tegretol (TN) |
Trigeminal neuralgia [DS:H01638] |
| D00334 | Gemfibrozil (JAN/USP/INN) | Lopid (TN) | Types IV and V hyperlipidemia [DS:H01635] |
| D01155 | Gemcitabine hydrochloride (JAN/USP) | Gemzar (TN) |
Ovarian cancer [DS:H00027] Breast cancer [DS:H00031] Non-small cell lung cancer [DS:H00014] Pancreatic cancer [DS:H00019] |
| D01382 | Metharbital (JAN/INN) | Gemonil (TN) | |
| D02073 | Gemeprost (JAN/USAN/INN) | Preglandin (TN) | |
| D02368 | Gemcitabine (USAN/INN) | ||
| D02471 | Gemifloxacin mesylate (USAN) | Factive (TN) | |
| D03259 |
Gemtuzumab ozogamicin (USAN) Gemtuzumab ozogamicin (genetical recombination) (JAN) Gemtuzumab (INN) |
Mylotarg (TN) | Acute myeloid leukemia (CD33-positive) [DS:H00003] |
| D04309 | Gemcabene calcium (USAN) | ||
| D04310 | Gemcadiol (USAN/INN) | ||
| D04312 | Gemopatrilat (USAN/INN) | ||
| D06144 | Tigemonam dicholine (USAN) | Tigemen (TN) | |
| D08012 | Gemifloxacin (INN) | Factiv (TN) | |
| D10222 | Gemcitabine elaidate (USAN/INN) | ||
| D10433 | Vibegron (JAN/USAN/INN) |
Beova (TN) Gemtesa (TN) |
|
| D10502 | Gemigliptin (INN) | ||
| D11417 | Pemigatinib (JAN/USAN/INN) | Pemazyre (TN) |
Cholangiocarcinoma (FGFR2 fusion positive) [DS:H00046] Myeloid-lymphoid neoplasms (FGFR1 rearrangement) [DS:H01605 H01612 H02410 H00007 H00011 H01613 H01463 H00005 H01464 H01613 H01892 H00008 H00001 H00002] |
| D11611 | Infigratinib phosphate (USAN) | Truseltiq (TN) | Cholangiocarcinoma (FGFR2 fusion or other rearrangement) [DS:H00046] |
| D12291 | Tovorafenib (USAN/INN) | Ojemda (TN) | Pediatric low-grade glioma (BRAF fusion or BRAF rearrangement, or BRAF V600 mutation positive) [DS:H00042] |
| D12387 | Fosgemcitabine palabenamide (USAN/INN) | ||
| D12750 | Sugemalimab (INN) |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |